{"text": "Pull-down assay .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "HEK293T cells were transfected with <extra_id_0> RUNX1 <extra_id_2> Protein <extra_id_1> or <extra_id_0> RUNX3 <extra_id_2> Protein <extra_id_1> using the Lipofectamine 2000 reagent ( Invitrogen ) according to the manufacturer 's instruction .", "event": "<extra_id_0> <extra_id_0> Gene_expression transfected <extra_id_1> <extra_id_0> Theme RUNX1 <extra_id_1> <extra_id_0> Gene_expression transfected <extra_id_1> <extra_id_0> Theme RUNX3 <extra_id_1> <extra_id_1>"}
{"text": "Cells were lysed by sonication in HKMG buffer ( 10 mM Hepes , pH 7.9 , 100 mM KCl , 5 mM MgCl2 , 10 % glycerol , 1 mM DTT , 0.5 % Nonidet P-40 ) containing a protease inhibitor cocktail ( Roche Diagnostics ) .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "The cell lysate was precleared using streptavidin-agarose beads ( GE Healthcare ) , incubated with biotinylated double-stranded oligonucleotides containing the wild-type or mutated RUNX binding sites , and polydeoxyinosinicdeoxycytidylic acid ( Sigma-Aldrich ) .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "A combination of all three oligonucleotides containing the mutated or the wild-type binding sites was used in the assay .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "DNA - bound proteins were collected with streptavidin-agarose beads , washed with HKMG buffer , and finally resuspended in NuPAGE loading buffer ( Invitrogen Life Technologies ) , heated to 70degreesC for 10 min , and separated on a NuPAGE 4-12 % Bis-Tris gel ( Invitrogen Life Technologies ) .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "The proteins were electroblotted onto a PVDF membrane ( GE Healthcare ) and detected using <extra_id_0> RUNX1 <extra_id_2> Protein <extra_id_1> or <extra_id_0> RUNX3 <extra_id_2> Protein <extra_id_1> antibodies described in the previous section .", "event": "<extra_id_0> <extra_id_1>"}
